Nanotechnology and medicine PowerPoint Presentation

Slide 1 -

Nanotechnology and medicine Dina Khater – 3 April 2011 - SFC

Slide 2 -

Nanotechnology Nano is 1×10−9 m. Nanotechnology deals with structures with a size range of 1 to 100 nm. It`s based upon molecular self-assembly

Slide 3 -

Nanotechnology

Slide 4 -

Nanotechnology AT the nano level materials begin to demonstrate entirely new chemical and physical properties. Materials can be stronger, lighter and highly soluble , reducing of melting point ……

Slide 5 -

Nanotechnology BY manipulating the arrangement of atoms nanotechnology may be able to create many new materials and devices .

Slide 6 -

Nanotechnology Nanotechnology has several application on many fields such as : o Medicine o Electronics o Energy production o water processing ………

Slide 7 -

Nanomedicine •It is the medical application of nanotechnology. •It`s defined as the repair, construction and control of human biological systems using devices built upon nanotechnology standards.

Slide 8 -

Nanomedicine • Nanostructured materials, engineered enzymes and many other products of biotechnology will be very useful in the future. •High-sophisticated, medically programmable nanomachines and nanorobots are developed.

Slide 9 -

Nanomedicine That will allow doctors to approach the human body at the cellular and molecular levels. Interventions such as repairing damaged tissues (bone, muscle, nerve) will be possible.

Slide 10 -

Nanomedicine Nanomedicine is a huge industry. Sales reached 6.8 billion dollars in 2004. USA and European Union are investing billions of dollars and plan to invest more in the future.

Slide 11 -

Nanomedicine Nanotechnology can be used in many fields of medicine •Pharmacy •visualization •cancer •Diagnoses •surgery

Slide 12 -

Nanopharmacy It can help in increasing the bioavailability of the drug and biodistributions . So it will reduce side effects . It can icrease the solubility of the drug.

Slide 13 -

Nanopharmacy It can help giving suspensions as IV injection.

Slide 14 -

Nanopharmacy Nanostructures have large surface area which means more room for functional groups which can bind with tumor cells.

Slide 15 -

Nanopharmacy the biodistribution of these nanoparticles is mostly unknown due to the difficulty in targeting specific organs in the body. In mice, gold selectively targeted certain organs based on their size and charge.

Slide 16 -

Nanopharmacy Positively-charged gold nanoparticles were found to enter the kidneys . negatively-charged gold nanoparticles remained in the liver and spleen. The nanoshells can be targeted to bond to cancerous cells by conjugating antibodies or peptides to the nanoshell surface.

Slide 17 -

Nanomedicine and cancer By irradiating the area of the tumor with an infrared laser, which passes through flesh without heating it, the gold is heated sufficiently to cause death to the cancer cells.

Slide 18 -

photodynamic therapy If the particle is metal, energy from the Light may also be used to produce high energy ,oxygen molecules which will chemically react with and destroy most organic molecules that are next to them (like tumors).

Slide 19 -

photodynamic therapy Unlike chemotherapy it does not leave a “toxic trail”

Slide 20 -

Surgery This could solve the difficulties and blood leaks caused when the surgeon tries to re-stitch the arteries that have been cut during a kidney or heart transplant. The flesh welder could weld the artery perfectly

Slide 21 -

Surgery Nanoparticles of cadmium selenide (quantum dots) glow when exposed to ultraviolet light. When injected, they seep into cancer tumors. The surgeon can see the glowing tumor, and use it as a guide for more accurate tumor removal.

Slide 22 -

References http://en.wikipedia.org/wiki/Nanomedicine#cite_note-6 http://www.nanoed.org/concepts_apps/AuNanoShells/InDepthIntroPg1.html#InDepthIntro http://www.nanomedicinecenter.com/drug-delivery/

Slide 23 -

Thanks Thanks Dina Nabil Khater Khater_dina@yahoo.com Supervised by prof. Doctor: Wael Sami Industrial pharmacy department SPC supervisor

Slide 24 -

ppt slide no 24 content not found

Slide 25 -

ppt slide no 25 content not found

Slide 26 -

ppt slide no 26 content not found

Slide 27 -

ppt slide no 27 content not found

Slide 28 -

ppt slide no 28 content not found

Slide 29 -

ppt slide no 29 content not found

Slide 30 -

ppt slide no 30 content not found

Slide 31 -

ppt slide no 31 content not found

Slide 32 -

Sensor test chips containing thousands of nanowires, able to detect proteins and other biomarkers left behind by cancer cells, could enable the detection and diagnosis of cancer in the early stages from a few drops of a patient's blood.

Slide 33 -

ppt slide no 33 content not found

Slide 34 -

ppt slide no 34 content not found

Slide 35 -

ppt slide no 35 content not found

Slide 36 -

ppt slide no 36 content not found

Slide 37 -

ppt slide no 37 content not found

Slide 38 -

ppt slide no 38 content not found

Slide 39 -

ppt slide no 39 content not found

Slide 40 -

ppt slide no 40 content not found

Slide 41 -

ppt slide no 41 content not found

Slide 42 -

ppt slide no 42 content not found

Slide 43 -

ppt slide no 43 content not found

Slide 44 -

ppt slide no 44 content not found

Slide 45 -

ppt slide no 45 content not found

Slide 46 -

ppt slide no 46 content not found

Slide 47 -

ppt slide no 47 content not found

Slide 48 -

ppt slide no 48 content not found

Slide 49 -

ppt slide no 49 content not found

Slide 50 -

ppt slide no 50 content not found

Slide 51 -

ppt slide no 51 content not found

Slide 52 -

ppt slide no 52 content not found

Slide 53 -

ppt slide no 53 content not found

Slide 54 -

ppt slide no 54 content not found

Slide 55 -

ppt slide no 55 content not found

Slide 56 -

ppt slide no 56 content not found

Slide 57 -

ppt slide no 57 content not found

Slide 58 -

ppt slide no 58 content not found

Slide 59 -

ppt slide no 59 content not found

Slide 60 -

ppt slide no 60 content not found

Slide 61 -

ppt slide no 61 content not found

Slide 62 -

ppt slide no 62 content not found

Slide 63 -

ppt slide no 63 content not found

Slide 64 -

ppt slide no 64 content not found

Slide 65 -

ppt slide no 65 content not found

Slide 66 -

ppt slide no 66 content not found

Slide 67 -

ppt slide no 67 content not found

Slide 68 -

ppt slide no 68 content not found

Slide 69 -

ppt slide no 69 content not found

Slide 70 -

ppt slide no 70 content not found

Slide 71 -

ppt slide no 71 content not found

Slide 72 -

ppt slide no 72 content not found

Slide 73 -

ppt slide no 73 content not found

Slide 74 -

ppt slide no 74 content not found

Slide 75 -

ppt slide no 75 content not found